dorminant mycobacteria in...

12
DORMINANT MYCOBACTERIA IN NIGERIA Agatha Ani 1 , Torbjørn Bruvik 3 , John Idoko 2 and Ulf, Dahle 3 1. Department of Medical Microbiology 2 Department of Medicine University of Jos PMB 2084 Jos, Nigeria 3. The Norwegian Institute of Public Health Oslo

Upload: others

Post on 29-Jan-2021

4 views

Category:

Documents


0 download

TRANSCRIPT

  • DORMINANT MYCOBACTERIA IN NIGERIA

    Agatha Ani1 , Torbjørn Bruvik3, John Idoko2

    and Ulf, Dahle3

    1. Department of Medical Microbiology 2 Department of Medicine

    University of JosPMB 2084Jos, Nigeria

    3. The Norwegian Institute of Public Health Oslo

  • NIGERIA: OVERVIEW

  • OVERVIEW OF TUBERCULOSIS IN NIGERIA

    TB is a major cause of morbidity and mortality in Nigeria,TB incidence in Nigeria is rated at 311/100,000 with about 317/100,000 new cases (WHO, 2008). Second highest for TB disease burden in Africa (worsened by of HIV/AIDS, Ranks 5th among the 22 high TB burden countries in the world (WHO Global TB Report, 2008).Recent sentinel survey (2006), reported 30% HIV prevalence among TB casesEmergence of drug resistant M. tuberculosis presents additional burden to the control of TB.

    Estimated that 1.9% of the new TB cases have MDR-TB

  • INTRODUCTION

    The epidemiology of TB in Nigeria is poorly understood.

    Low case detection rates and poor treatment outcome among others are likely to enhance TB transmission in Nigeria

    Genetic methods are required for TB epidemiological studies.

    Spoligotyping, a PCR based method that detects the presence or absence of a 43 spacers between short direct repeats on M. tuberculosis genome is well reported.

    Spoligotyping is considered relatively less expensive and reproducible method that allows the use of computerised data base (e.g. SpolDB4). Generated data can be analysed and compared to the global M tuberculosis population

  • MATERIALS AND METHODS

    Pulmonary isolates of M tuberculosis from children and adults in Jos, Nigeria were tested.

    Isolation and drug susceptibility of M. tuberculosis (on LJ slopes) were performed at the Research Laboratory, Department of Medical Microbiology, University of Jos, Nigeria

    DNA was extracted from 111 of the isolates and shipped to the Division of Infectious Disease Control, Norwegian Institute of Public Health Oslo for Spoligotyping.

    Spoliopatterns were assigned to families and subfamilies using SpolDB4 Spotclust databases.

    .

  • SPOLIGOTYPING

  • RESULTS (TABLE1)

    Spoligotypes of M tuberculosis from TB Centres in Jos, Nigeria N(%)

    Spoligo- (Family)

    ABJ APIN ECWA

    JUTH PH ZW Total N(%)

    LAM

    8 (72)

    8 (80)

    21 (88)

    27 (69)

    11 (73)

    9 (75)

    84 (77)

    Haarlem

    0 0 0 8(21) 1 1 10(9)

    X3

    1(9) 1(10) 2(8) 0 1(7) 1(8) 6(5)

    T&F

    1(9) 1(10) 1(4) 2(5) 1(7) 6(5)

    EA

    0 0 0 0 1(7) 1(8) 2(2)

    M africanum

    1(9) 0 0 0 0 0 1(1)

    Untypable

    0 0 0 2(5) 0 0 2(2)

    Total examined

    11 10 24 39 15 12 111

  • RESULTS FIG 1. DENDOGRAM BASED ON SPOLIGOPATTERN

  • Discussion

    The dominance of few M. tuberculosis lineages indicate a high rate of transmission, high levels of synonymous import or a highly conserved genotype.

    It remains to be confirmed whether the large cluster of identical LAM10 represent an outbreak.

    Alternatively the low level of genetic variation among the non-identical isolates within this subfamily may indicate recent expansion of this group in Jos or simultaneous import from neighboring countries.

    Similar patterns, yet less obvious, have been shown in other West-African countries.

  • Conclusion

    These findings suggest a recent local expansion of M. tuberculosis in West Africa. An extended population-based study is needed to confirm the hypothesis

  • ACKNOWLEDGEMENT

    The University of Jos, Jos, Nigeria

    The Norwegian Institute of Public Health Oslo

    APIN+ Jos University Hospital, Nigeria

    EDCTP Forum

  • APPRECIATION

    THANK YOU!

    DORMINANT MYCOBACTERIA IN NIGERIANIGERIA: OVERVIEWOVERVIEW OF TUBERCULOSIS IN NIGERIAINTRODUCTIONMATERIALS AND METHODSSPOLIGOTYPINGRESULTS (TABLE1)RESULTS FIG 1. DENDOGRAM BASED ON SPOLIGOPATTERNDiscussion ConclusionACKNOWLEDGEMENTAPPRECIATION